
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.320 | 1.530 | 0.210 |
Stocks | 98.680 | 98.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.562 | 17.652 |
Price to Book | 2.960 | 3.315 |
Price to Sales | 1.960 | 2.154 |
Price to Cash Flow | 13.566 | 13.941 |
Dividend Yield | 3.262 | 2.951 |
5 Years Earnings Growth | 17.739 | 14.041 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 33.940 | 30.921 |
Financial Services | 28.990 | 20.937 |
Industrials | 12.720 | 16.393 |
Consumer Defensive | 12.110 | 12.577 |
Technology | 4.660 | 3.505 |
Consumer Cyclical | 4.020 | 5.329 |
Communication Services | 2.690 | 2.888 |
Basic Materials | 0.870 | 8.298 |
Number of long holdings: 44
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 9.34 | 89.48 | +0.99% | |
Novartis | CH0012005267 | 9.20 | 96.65 | +0.99% | |
Roche Holding Participation | CH0012032048 | 9.09 | 309.00 | +4.22% | |
Zurich Insurance Group | CH0011075394 | 8.35 | 597.80 | +0.84% | |
Swiss Re | CH0126881561 | 4.96 | 145.85 | +1.18% | |
ABB | CH0012221716 | 4.89 | 49.51 | +1.35% | |
UBS Group | CH0244767585 | 4.89 | 28.01 | +1.27% | |
Lonza Group | CH0013841017 | 4.36 | 543.40 | +1.76% | |
Swiss Life Holding | CH0014852781 | 3.93 | 781.00 | +1.27% | |
Alcon | CH0432492467 | 3.58 | 79.06 | +1.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Strategy Fund Yield CHF K 1 acc | 1.54B | 2.17 | -1.55 | 0.85 | ||
UBS Strategy Fund Growth CHF Q acc | 641.99M | 4.07 | 1.00 | 3.39 | ||
UBS Equity S European High Dividend | 160.29M | 4.85 | 2.90 | 2.34 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review